skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Recently n January bought 5150 shares pmif.my brokerage showed a yield of 3.5%on a monthly distribution of .0230.your site has same monthly rate and a yield of 2.7. I have just received my first Monthly payment of 118.45 on book value of 100126$ . this would be a yield of just 1.42%.can you analyze and confirm what yield I can count on?And any suggestions for any other options in fixed income to yield 3%?

Read Answer Asked by Larry on February 06, 2019
Q: Hi 5i: Am considering SCHD .. Schwab U.S. Dividend Equity ETF (symbol not in your database) for a medium to long term hold in my non-registered account. It tracks the Dow Jones U.S. Dividend 100 index. Seems to have a good track record and 5 star rating from Morningstar with a low mer of 0.07%. What is your opinion of this ETF ? Would you prefer VUN or VGG ? Any other suggestions appreciated.
Thanks as always for your great advice !
Steve
Read Answer Asked by STEVEN on February 06, 2019
Q: I am looking to add an industrial REIT (either SMU.UN, WIR.UN, or DIR.UN) to an RESP for a 5-8 year hold. Funds are not needed for another 8 years. Which of the 3 REITS listed would you recommend purchasing and why do you prefer it over the other 2?
Read Answer Asked by Linda on February 06, 2019
Q: Hello: I have been reading the last ROB and the Invest like a legend article. I find it interesting most of those interviewed mention broad index funds. You have mentioned these many times but hope you might address these funds again with a portfolio of index funds. Thank you in advance. Barbara
Read Answer Asked by Barbara on February 06, 2019
Q: Hi team,

I don't see any questions on this company Cardiol Therapeutics Inc. (CRDL) that did a recent IPO on TSX and hit a 52 week high today. It seems they are in a (speculative) cannabinoid arena with some drugs coming into phase 1 stages in 2019.
What is management history (CEO, CFO, etc.), board of directors, ...ie are they a solid team?
They had a string of announcements (LOI's, exclusive agreements, etc) in 2017 but no real follow-up news in 2018 wrt these signings.
Does their product pipeline seem promising?
How might it compare to Cannimed wrt therapeutic applications?

Is it a company to just watch for now given it's very recent IPO? So many IPO's flop in the first 6 months thus the caution.

Appreciate your insight!

Cheers,
SteveMc
Read Answer Asked by Stephen on February 06, 2019
Q: after reading your recent market update, it appears Canadians really aren’t looking to slow down their borrowings, even thought the debt to income net of taxes is an all time high, as this ratio is now like 170 compared to 100 a few years ago.

with regulations getting tougher with the big banks, some Canadians can look to get funding from alternative lenders like Equitable Bank (EQB.TO).

in this economic environment, do you think the timing is right for EQB stock price to stream roll upwards, like bigly over the next few years?
Read Answer Asked by Tom on February 06, 2019